| Allyson Duda, NP | |
|
3251 N Windsong Dr, Prescott Valley, AZ 86314-1222 | |
| (928) 772-2582 | |
| Not Available |
| Full Name | Allyson Duda |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 3251 N Windsong Dr, Prescott Valley, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265028914 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 226536 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
| Banner Primary Care Physicians Arizona Llc | 6406020155 | 182 |
News Archive
In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.
A new study demonstrates that higher-protein meals improve perceived appetite and satiety in overweight and obese men during weight loss. According to the research, published in Obesity, higher-protein intake led to greater satiety throughout the day as well as reductions in both late-night and morning appetite compared to a normal protein diet.
Today, Formatech has selected the next candidate for its Fillanthropy Program: ViroMed's VM206 therapeutic cancer vaccine. Under the Fillanthropy Program, Formatech will donate the services required to aseptically fill and finish one lot of the vaccine to support ViroMed's upcoming clinical trials.
Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.
› Verified 7 days ago
| Entity Name | Banner Primary Care Physicians Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417238908 PECOS PAC ID: 6406020155 Enrollment ID: O20111115000898 |
News Archive
In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.
A new study demonstrates that higher-protein meals improve perceived appetite and satiety in overweight and obese men during weight loss. According to the research, published in Obesity, higher-protein intake led to greater satiety throughout the day as well as reductions in both late-night and morning appetite compared to a normal protein diet.
Today, Formatech has selected the next candidate for its Fillanthropy Program: ViroMed's VM206 therapeutic cancer vaccine. Under the Fillanthropy Program, Formatech will donate the services required to aseptically fill and finish one lot of the vaccine to support ViroMed's upcoming clinical trials.
Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.
› Verified 7 days ago
| Entity Name | Banner Urgent Care Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316349855 PECOS PAC ID: 3678749496 Enrollment ID: O20111228000784 |
News Archive
In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.
A new study demonstrates that higher-protein meals improve perceived appetite and satiety in overweight and obese men during weight loss. According to the research, published in Obesity, higher-protein intake led to greater satiety throughout the day as well as reductions in both late-night and morning appetite compared to a normal protein diet.
Today, Formatech has selected the next candidate for its Fillanthropy Program: ViroMed's VM206 therapeutic cancer vaccine. Under the Fillanthropy Program, Formatech will donate the services required to aseptically fill and finish one lot of the vaccine to support ViroMed's upcoming clinical trials.
Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.
› Verified 7 days ago
| Entity Name | Banner Urgent Care Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609229764 PECOS PAC ID: 4284921610 Enrollment ID: O20160928001188 |
News Archive
In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.
A new study demonstrates that higher-protein meals improve perceived appetite and satiety in overweight and obese men during weight loss. According to the research, published in Obesity, higher-protein intake led to greater satiety throughout the day as well as reductions in both late-night and morning appetite compared to a normal protein diet.
Today, Formatech has selected the next candidate for its Fillanthropy Program: ViroMed's VM206 therapeutic cancer vaccine. Under the Fillanthropy Program, Formatech will donate the services required to aseptically fill and finish one lot of the vaccine to support ViroMed's upcoming clinical trials.
Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allyson Duda, NP 743 Miller Valley Rd, Prescott, AZ 86301-1813 Ph: (928) 777-9600 | Allyson Duda, NP 3251 N Windsong Dr, Prescott Valley, AZ 86314-1222 Ph: (928) 772-2582 |
News Archive
In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.
A new study demonstrates that higher-protein meals improve perceived appetite and satiety in overweight and obese men during weight loss. According to the research, published in Obesity, higher-protein intake led to greater satiety throughout the day as well as reductions in both late-night and morning appetite compared to a normal protein diet.
Today, Formatech has selected the next candidate for its Fillanthropy Program: ViroMed's VM206 therapeutic cancer vaccine. Under the Fillanthropy Program, Formatech will donate the services required to aseptically fill and finish one lot of the vaccine to support ViroMed's upcoming clinical trials.
Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock.
The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.
› Verified 7 days ago
Mrs. Holly Ann Allred, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6386 E Ashton Pl, Prescott Valley, AZ 86314 Phone: 928-533-3971 | |
Reneallia Bennett, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3075 N Windsong Dr Ste A, Prescott Valley, AZ 86314 Phone: 928-350-8780 Fax: 888-674-1228 | |
Cheryl Anne Wagner, ARNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 7600 E Florentine Rd, Prescott Valley, AZ 86314 Phone: 928-772-1610 | |
Laura Finkbeiner, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7700 E Florentine Rd Ste 101, Prescott Valley, AZ 86314 Phone: 605-685-3995 | |
Kelly L Marshall, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7700 E Florentine Rd Ste 101, Prescott Valley, AZ 86314 Phone: 928-442-8710 Fax: 928-442-8742 | |
Lindsey M Robbins, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3251 N Windsong Dr, Prescott Valley, AZ 86314 Phone: 928-772-2582 | |
Amy M Thein, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3345 N Windsong Dr, Prescott Valley, AZ 86314 Phone: 928-445-5211 |